| Unique ID issued by UMIN | UMIN000060727 |
|---|---|
| Receipt number | R000069471 |
| Scientific Title | Identification of oral bacteria involved in mild cognitive impairment and research on methods for controlling them |
| Date of disclosure of the study information | 2026/03/01 |
| Last modified on | 2026/02/21 18:01:06 |
Identification of oral bacteria involved in mild cognitive impairment and research on methods for controlling them
Oral bacteria involved in mild cognitive impairment
Identification of oral bacteria involved in mild cognitive impairment and research on methods for controlling them
Oral bacteria involved in mild cognitive impairment
| Japan |
Mild cognitive impairment
| Psychiatry |
Others
NO
The objective of this study is to identify oral bacteria associated with the promotion of Alzheimer's disease onset, one of the pathophysiological hypotheses involving brain inflammation.
Bio-availability
Exploratory
Others
Not applicable
Whether dementia developed during the observation period
Depression, anxiety, motivation, happiness, daily life intensity
Observational
| 20 | years-old | <= |
| 90 | years-old | > |
Male and Female
(1) Patient group: 1) Diagnosed with mild cognitive impairment according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) by the American Psychiatric Association, and 2) scored 25 or below on the Montreal Cognitive Assessment (MoCA)-J, which evaluates multiple cognitive functions, and 20 or above on the Mini Mental State Examination (MMSE)-J.
(2) Control group: Outpatients of the Department of Oral and Maxillofacial Surgery at our hospital with normal cognitive function (MoCA score 26 points or more, MMSE-J score 28 points or more).
1) History of head trauma, brain tumors, or neurodegenerative diseases.
2) For the patient group, outpatient primary care physicians have already prescribed anti-dementia drugs, steroids, or antibiotics that affect oral bacteria.
225
| 1st name | Toshio |
| Middle name | |
| Last name | Matsubara |
Yamaguchi University Graduate School of Medicine
Division of Neuropsychiatry, Department of Neuroscience
7550041
1-1-1 Minamikogushi, Ube, Yamaguchi
0836222255
t-matsu@yamaguchi-u.ac.jp
| 1st name | Toshio |
| Middle name | |
| Last name | Matsubara |
Yamaguchi University Graduate School of Medicine
Division of Neuropsychiatry, Department of Neuroscience
7558505
1-1-1 Minamikogushi, Ube, Yamaguchi
0836222255
t-matsu@yamaguchi-u.ac.jp
Yamaguchi University
General Incorporated Foundation Yamaguchi Institute for Comprehensive Research on Aging
Non profit foundation
Center For Clinical Research, Yamaguchi University Hospital
1-1-1 Minamikogushi, Ube, Yamaguchi
0836-22-2428
clin_res@yamaguchi-u.ac.jp
NO
山口大学医学部附属病院(山口県)
| 2026 | Year | 03 | Month | 01 | Day |
Unpublished
Open public recruiting
| 2019 | Year | 12 | Month | 20 | Day |
| 2020 | Year | 07 | Month | 31 | Day |
| 2020 | Year | 08 | Month | 01 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
The patient group will undergo cognitive function testing, psychiatric assessment, and oral bacterial sampling during the observation period (at study enrolment, one year post-enrolment, and two years post-enrolment).
The control group will undergo cognitive function testing, psychiatric assessment, and oral bacterial sampling only at study enrolment.
DNA will be extracted from the sampled oral bacteria for comprehensive oral microbiota analysis.
| 2026 | Year | 02 | Month | 21 | Day |
| 2026 | Year | 02 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069471